2023 CBIIC in Suzhou Industrial Park on September 25-27, 2023.
Chief Scientist, Megarobo Technologies Co.
Dr. Cheng-Zhi Wang was graduated from Peking University Health Science Center. He then did tumor targeted therapy and gene regulation research at the Cancer Research Center of Missouri University (USA), the National Institute of Biological Sciences (NIBS) and the Institute of Biophysics of the Chinese Academy of Sciences. After shifting to the industry, Dr. Wang has successively engaged in innovative drug R&D and clinical trials in well-known CROs and pharmaceutical companies. Dr. Wang is currently the Vice President of the Life Science Business Unit and Chief Scientist of Megarobo.